None of the 9 IPF-specific quality-of-life instruments currently in use meet the criteria for a full Category A ...
Cord blood transplantation (CBT) conditioning intensity was associated with posttransplant outcomes that varied by age among ...
Experts in Germany, Austria, and Switzerland issued consensus recommendations for administering onasemnogene abeparvovec in ...
An AI model identified 5 categories of pathogenic processes that contribute to pulmonary involvement in neuronopathic Gaucher ...
Whole-body metabolic modeling may be a promising approach to studying ultrarare mitochondrial disorders such as MNGIE or TK2d.
Results of a real-world study found that icatibant is safe and effective for the treatment of acute HAE attacks.
Ivosidenib monotherapy led to high response rates and prolonged survival in patients with IDH1-mutated myelodysplastic syndrome (MDS).
In patients with infantile-onset Pompe disease, higher-dosage ERT regimens were linked to higher peaks in motor function, FVC, and strength.
Recent HR-MDS failures highlight the need to match trial populations, endpoints, and therapies to disease biology.
Mineralocorticoid receptor antagonists offer minimal incremental benefit in patients with ATTR-CM receiving disease-modifying therapy, a study shows.
After applying for accelerated FDA approval of delpacibart zotadirsen in DMD, Avidity launched a confirmatory trial of the ...
Telomere-related gene variants contribute to idiopathic pulmonary fibrosis (IPF) susceptibility, according to a new study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results